Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prometheus: MTX + GC vs GC in PM/DM
NCT00651040Phase 3Completed
- Sponsor
- Kennedy Institute of Rheumatology
- Start
- May 2008
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate in polymyositis (PM), dermatomyositis (DM), sponsored by Kennedy Institute of Rheumatology. Started May 2008; status: completed.
02
Drugs
methotrexate
03
Conditions
polymyositis (PM)dermatomyositis (DM)
Beyond the preview
Go deeper on NCT00651040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651040.